Last reviewed · How we verify
Trimo-San vaginal gel
Trimo-San is a vaginal gel containing lactic acid and other ingredients that restore and maintain the normal acidic pH of the vaginal environment to prevent bacterial vaginosis.
Trimo-San is a vaginal gel containing lactic acid and other ingredients that restore and maintain the normal acidic pH of the vaginal environment to prevent bacterial vaginosis. Used for Bacterial vaginosis prevention and treatment, Maintenance of normal vaginal flora.
At a glance
| Generic name | Trimo-San vaginal gel |
|---|---|
| Also known as | Trimo-San |
| Sponsor | The University of Texas Health Science Center, Houston |
| Drug class | Vaginal pH regulator / Probiotic adjunct |
| Modality | Small molecule |
| Therapeutic area | Gynecology / Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
The gel works by lowering vaginal pH to create an acidic environment that inhibits the growth of pathogenic bacteria associated with bacterial vaginosis while promoting the growth of beneficial lactobacilli. This pH restoration helps restore the normal vaginal microbiota and prevents recurrent infections.
Approved indications
- Bacterial vaginosis prevention and treatment
- Maintenance of normal vaginal flora
Common side effects
- Local irritation or discomfort
- Allergic reaction to components
Key clinical trials
- Postmenopausal Pessary Users: Estrogen Versus Trimosan (PHASE4)
- Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Trimo-San vaginal gel CI brief — competitive landscape report
- Trimo-San vaginal gel updates RSS · CI watch RSS
- The University of Texas Health Science Center, Houston portfolio CI